GC
MGNX icon

GMT Capital’s MacroGenics MGNX Stock Holding History

GMT Capital’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-328,278
Closed -$3.57M – 88
2019
Q4 		$3.57M Sell
328,278
-1,013,222
-76% -$10M 0.14% 51
2019
Q3 		$17.1M Buy
1,341,500
+292,400
+28% +$4.21M 0.63% 38
2019
Q2 		$17.8M Buy
1,049,100
+793,900
+311% +$13.6M 0.62% 37
2019
Q1 		$4.59M Buy
+255,200
New +$4.41M 0.15% 55

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

GMT Capital's MGNX Position: Q1 2020 in Review

GMT Capital sold out of MacroGenics (MGNX) in Q1 2020, closing a stake of 328,278 shares — an estimated $3.57M sold.

GMT Capital first reported a position in MGNX in Q1 2019 and held it in 4 quarters. The position peaked at $17.8M in Q2 2019. 122 funds tracked by Wall St. Rank hold MGNX as of Q1 2020.

  • GMT Capital reported no remaining MacroGenics position as of Q1 2020 after selling out during the quarter.
  • GMT Capital sold 328,278 MacroGenics shares in Q1 2020, an estimated $3.57M.
  • GMT Capital first reported a position in MacroGenics in Q1 2019 and held it in 4 quarters.
  • GMT Capital's MacroGenics position peaked at $17.8M in Q2 2019.
  • 122 funds tracked by Wall St. Rank held MacroGenics as of Q1 2020.

Based on GMT Capital's 13F filing for Q1 2020, filed 13 May 2020.